Drug Allergy
Conditions
Brief summary
Testing a clinical decision tool (BL-Predictor)
Interventions
DIAGNOSTIC_TESTBL-Predicter
To Clinically validate the BL-Predictor toll by a randomised conytrolled ttrial
Sponsors
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Masking description
If there are other parties who are masked in the clinical trial besides those listed above, use this space to describe those parties.
Intervention model description
If there are other parties who are masked in the clinical trial besides those listed above, use this space to describe those parties.
Eligibility
Sex/Gender
ALL
Age
14 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* signed informed consnet
Exclusion criteria
* Use of immunomodulators, antihistamines and corticosteroids
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The main goal of this project is to test a cliniacl decision toll to stratify BL allergic pataients in low and mediaum- anf high-risk | April 2029- june 2027 | And to carry out a deep dissection of the cellular mechanisms of B cells sensitization and basophil and neutrophil activation in BL-IRs to develop accurate in vitro diagnostic test |
Contacts
Primary ContactMarina Labella Alvarez MLB Bonilla Toyos
Outcome results
None listed